Citadel Advisors LLC 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:23 pm Sale | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 2,960,081 3.000% | -112,506 (-3.66%) | Filing |
| 2024-02-14 4:57 pm Purchase | 2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 3,072,587 5.000% | 91,263 (+3.06%) | Filing |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 2,981,324 5.700% | 116,524 (+4.07%) | Filing |
| 2022-02-14 06:12 am Sale | 2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 2,864,800 5.600% | -299,601 (-9.47%) | Filing |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 3,164,401 7.000% | 218,450 (+7.42%) | Filing |
| 2020-09-28 4:03 pm Purchase | 2020-09-17 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 2,945,951 6.500% | 2,945,951 (New Position) | Filing |